BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Sunesis Pharmaceuticals, Inc. 

395 Oyster Point Boulevard
Suite 400
South San Francisco  California  94080  U.S.A.
Phone: 650-266-3500 Fax: 650-266-3501


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Pharmaceutical

Segment
Biotechnology





 Company News
Sunesis Pharmaceuticals, Inc. (SNSS) Announces Presentation Of Positive Updated Results From Ongoing MD Anderson-Sponsored Trial Of Vosaroxin In AML And High-Risk MDS At American Society of Hematology Annual Meeting 12/9/2014 10:19:28 AM
Sunesis Pharmaceuticals, Inc. (SNSS) Announces Presentation Of Results From Phase 3 VALOR Trial At American Society of Hematology Annual Meeting 12/8/2014 6:34:41 AM
SSF's Sunesis Pharmaceuticals, Inc. (SNSS) Believes It Can End 40 Year AML Drought Despite "Failed" Phase 3 Study 12/8/2014 6:31:58 AM
Sunesis Pharmaceuticals, Inc. (SNSS) To Host Conference Call And Slide Webcast Tuesday, December 9 Following Presentation Of Phase 3 12/5/2014 10:34:55 AM
Sunesis Pharmaceuticals, Inc. (SNSS) Announces Publication Of REVEAL-1 Trial Results In The British Journal Of Haematology 11/24/2014 12:38:30 PM
Sunesis Pharmaceuticals, Inc. (SNSS) Announces Publication Of Vosaroxin Phase 1b/2 AML Trial Results In Haematologica 11/19/2014 9:32:58 AM
Sunesis Pharmaceuticals, Inc. (SNSS) Announces Late-Breaking Presentation Of Phase 3 VALOR Trial At American Society of Hematology Annual Meeting 11/17/2014 10:42:13 AM
Sunesis Pharmaceuticals, Inc. (SNSS) Reports Third Quarter 2014 Financial Results And Recent Highlights 11/10/2014 8:12:14 AM
Sunesis Pharmaceuticals, Inc. (SNSS) To Present At Upcoming Investor Conferences 11/5/2014 10:12:32 AM
Sunesis Pharmaceuticals, Inc. (SNSS) To Host Conference Call On November 10th To Discuss Third Quarter 2014 Financial Results And Recent Highlights 11/3/2014 8:37:43 AM
12345678910...